Osmotica Pharmaceuticals Plc (OSMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OSMT | AZN | AMGN | GILD | VRTX |
| Company | Osmotica Pharmaceuticals Plc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1400 | 91.09 | 327.52 | 119.27 | 453.83 |
| High | 1.1500 | 91.25 | 330.04 | 122.07 | 456.05 |
| Low | 1.0900 | 89.85 | 325.42 | 118.57 | 447.31 |
| Latest | 1.1100 | 89.86 | 326.01 | 121.36 | 449.52 |
| Change | -0.0200 | -1.49 | -0.73 | +2.58 | -5.44 |
| % Change | -1.77% | -1.63% | -0.22% | +2.17% | -1.20% |
| Volume | 296,500 | 5,975,400 | 2,517,400 | 7,959,000 | 1,349,800 |
| 20-Day Average Volume | 808,495 | 5,853,635 | 2,857,370 | 7,137,195 | 1,404,590 |
| Previous Close | 1.1300 | 91.35 | 326.74 | 118.78 | 454.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1000 | 90.84 | 331.82 | 123.40 | 440.31 |
| 20-Day Raw Stochastic | 47.37% | 25.87% | 40.08% | 30.29% | 68.38% |
| 20-Day Relative Strength | 42.07 | 54.13 | 52.63 | 49.39 | 57.23 |
| Weighted Alpha | -68.33 | +39.12 | +23.84 | +28.10 | +11.90 |
| Today's Opinion | 88% Sell | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.48% since 01/10/22 | -1.80% since 12/10/25 | +3.37% since 12/10/25 | +0.02% since 12/10/25 | +1.10% since 12/10/25 |
| Low | 1.0900 on 01/18/22 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 442.07 on 12/11/25 |
| High | 1.1800 on 01/11/22 | 91.79 on 12/15/25 | 330.04 on 12/17/25 | 123.74 on 12/11/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | +12.80% since 12/17/21 | +0.51% since 11/17/25 | -4.59% since 11/17/25 | -2.20% since 11/17/25 | +3.57% since 11/17/25 |
| Low | 0.9840 on 12/20/21 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 1.2500 on 12/23/21 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -40.96% since 10/18/21 | +15.66% since 09/17/25 | +18.67% since 09/17/25 | +8.11% since 09/17/25 | +16.11% since 09/17/25 |
| Low | 0.9801 on 12/17/21 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 2.0450 on 11/11/21 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -65.53% since 07/16/21 | +26.62% since 06/17/25 | +12.40% since 06/17/25 | +12.37% since 06/17/25 | +1.70% since 06/17/25 |
| Low | 0.9801 on 12/17/21 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 4.3800 on 08/13/21 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 69,469 | 283,315,264 | 175,943,280 | 147,367,984 | 115,431,992 |
| Shares Outstanding, K | 62,585 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 177,880,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -79,590,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 2,200,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -17,860,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.33 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/15/21 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/29/22 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.03 | 14.87 | 14.63 | 29.77 |